Aziyo Biologics Overview
Update this profile
Share Price
$5.88
(As of Thursday Closing)
Aziyo Biologics General Information
Description
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Contact Information
Aziyo Biologics Timeline
Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
Learn more
Aziyo Biologics Stock Performance
(As of Thursday Closing)
Stock Price
Previous Close
52 wk Range
Market Cap
Shares
Average Volume
EPS
$5.88
$6.06
$4.10 - $12.89
$80.1M
13.6M
10.5K
-$2.46
Aziyo Biologics Financials Summary
In Thousands, USD
TTM
31-Mar-2022
FY 2021
31-Dec-2021
FY 2020
31-Dec-2020
FY 2019
31-Dec-2019
EV
73,512
84,937
224,388
Revenue
46,001
47,390
42,682
42,901
EBITDA
(18,950)
(15,723)
(12,302)
(2,672)
Net Income
(27,914)
(24,832)
(21,825)
(11,939)
Total Assets
59,926
67,170
82,810
44,772
Total Debt
22,977
23,232
30,635
25,531
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Aziyo Biologics Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore Aziyo Biologics‘s full profile, request access.
Request a free trial
Aziyo Biologics Patents
2
Total Documents
Applications and Grants
000
Total Patents
Families
000
Granted
1
Pending
000
Expiring
in next 12 mo
Aziyo Biologics Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
US-20210269775-A1
Placental tissue compositions and methods
Pending
28-Feb-2020
0000000000
US-20190365948-A1
Lyophilized placental composite sheet and uses thereof
Abandoned
27-Jan-2017
000000000
Aziyo Biologics Executive Team (10)
Update this profile
Name
Title
Board Seat
Contact Info
Ronald Lloyd
Chief Executive Officer & Board Member
Matthew Ferguson
Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Thomas Englese
Executive
Darryl Roberts Ph.D
Executive Vice President
Courtney Guyer
Vice President
You’re viewing 5 of 10 executive team members. Get the full list »
Aziyo Biologics Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Aziyo Biologics Investors
Investor Name
Investor Type
Holding
Investor Since
Participating Rounds
Contact Info
This information is available in the PitchBook Platform. To explore Aziyo Biologics‘s full profile, request access.
Request a free trial